Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Cell And Gene Therapy Supply Chain or Logistics Market Report 2024

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components), By Application Area (Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up), By End User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization) – Market Size, Trends, And Global Forecast 2025-2034

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell And Gene Therapy Supply Chain/Logistics Market Definition

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.

The main types of software solutions are cell orchestration platforms, enterprise manufacturing systems, Inventory Management Systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform refers to a software or technological platform that facilitates the coordination, management, and integration of various processes and activities involved in cell therapy development, manufacturing, and delivery and is used to help streamline and automate tasks related to cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. They are deployed as a cloud-based solution; an on-premises solution in cryogenic shippers; cryogenic storage freezers; ultra-low freezers; cold chain management systems; shipment; storage medium; cryogenic packout kits; and other components. These solutions are used in applications such as donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up by end users including biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

The cell and gene therapy supply chain/logistics market covered in this report is segmented –

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:

1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools

2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)

3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization

4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting

5) By Logistics Management System: Route Optimization And Planning, Transportation Management

6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

7) By Quality Management System: Compliance Tracking, Quality Assurance And Control

8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

Cell And Gene Therapy Supply Chain/Logistics Market Size and growth rate 2025 to 2029: Graph

Cell And Gene Therapy Supply Chain/Logistics Market Size 2025 And Growth Rate

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance

Cell And Gene Therapy Supply Chain/Logistics Market Growth Forecast

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification.

Book your 30 minutes free consultation with our research experts

Contact Us

Cell And Gene Therapy Supply Chain/Logistics Market Driver: The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics

The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain or logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain or logistics market forward.

Cell And Gene Therapy Supply Chain/Logistics Market Driver: Personalized Medicine Boom Drives Cell And Gene Therapy Supply Chain And Logistics Market

The increasing demand for personalized medicine is expected to propel the growth of the cell and gene therapy supply chain/logistics market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Cell and gene therapy supply chain/logistics are used to deliver safely and effectively precision medicines to meet the unique needs of individual patients with incorporate temperature monitoring to maintain the integrity throughout the supply chain. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the cell and gene therapy supply chain/logistics market.

Global Cell And Gene Therapy Supply Chain/Logistics Market Major Players

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Global Cell And Gene Therapy Supply Chain/Logistics Market Trend: Advancements In Technology Propel Cell And Gene Therapy Logistics

Modern technology platforms are a key trend gaining popularity in the cell and gene therapy supply chain/logistics markets. Major companies operating in the market are developing modern technology platforms for cell and gene therapies to sustain their position in the market. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be integrated into the biopharma platform to facilitate better monitoring of the development and delivery of cell and gene therapies.

Global Cell And Gene Therapy Supply Chain/Logistics Market Trend: Next Generation Platforms Reshaping Cell And Gene Therapy Supply Chains

Major companies operating in the cell and gene therapy supply chain and logistics are focused on introducing next-generation solutions, such as the off-the-shelf cell orchestration platform. Off-the-shelf cell orchestration platforms are platforms that provide streamlined supply chain management, pre-designed modules, industry-proven processes, quick deployment, and integration. For instance, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite. OCELLOS Lite is a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. It allows companies to manage supply chain processes through the clinical phases of development into commercialization and can be deployed in weeks, which makes it one of the simplest and quickest solutions.

Cell And Gene Therapy Supply Chain/Logistics Market Merger And Acquisition: Cryoport Strengthens Global Supply Chain For Regenerative Medicine Through Acquisition Of Cell And Co Bioservices

In April 2022, Cryoport Systems LLC, a US-based temperature-controlled logistics services provider, acquired Cell&Co BioServices for $6.2 million. The acquisition helped Cryoport expand its global supply chain network and meet the needs of the regenerative medicine industry. Cell&Co BioServices is a France-based supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

Regional Outlook For The Global Cell And Gene Therapy Supply Chain/Logistics Market

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell and gene therapy supply chain/logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Cell And Gene Therapy Supply Chain/Logistics Market?

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell And Gene Therapy Supply Chain/Logistics Industry?

The cell and gene therapy supply chain/logistics research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy supply chain/logistics market statistics, including the cell and gene therapy supply chain/logistics industry's global market size, regional shares, competitors with a cell and gene therapy supply chain/logistics market share, detailed cell and gene therapy supply chain/logistics market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. This cell and gene therapy supply chain/logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cell And Gene Therapy Supply Chain/Logistics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $1.58 billion
Revenue Forecast In 2034 $2.44 billion
Growth Rate CAGR of 11.5% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization Subsegments: 1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management 6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes 7) By Quality Management System: Compliance Tracking, Quality Assurance And Control 8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

    3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

    4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Cell And Gene Therapy Supply Chain/Logistics Growth Analysis And Strategic Analysis Framework

    5.1. Global Cell And Gene Therapy Supply Chain/Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Cell And Gene Therapy Supply Chain/Logistics Market Growth Rate Analysis

    5.4. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Cell And Gene Therapy Supply Chain/Logistics Total Addressable Market (TAM)

    6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

    6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cell Orchestration Platform

    Enterprise Manufacturing System

    Inventory Management System

    Laboratory Information Management System

    Logistics Management System

    Patient Management System

    Quality Management System

    Tracking And Tracing System

    6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cloud-Based Solution

    On-Premises Solution

    6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cryogenic Shippers

    Cryogenic Storage Freezers

    Ultra-Low Freezers

    Cold Chain Management Systems

    Shipment

    Storage Medium

    Cryogenic Packout Kits

    Other Components

    6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Donor Eligibility Assessment

    Sample Collection

    Manufacturing

    Logistics

    Patient Verification

    Treatment Follow-Up

    6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Biobank

    Cell Therapy Lab

    Hospital

    Research Institute

    Commercial Organization

    6.6. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Workflow Management

    Scheduling And Coordination Tools

    6.7. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Production Planning And Control

    Manufacturing Execution Systems (MES)

    6.8. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Stock Tracking And Management

    Inventory Forecasting And Optimization

    6.9. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Sample Tracking And Management

    Data Management And Reporting

    6.10. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Route Optimization And Planning

    Transportation Management

    6.11. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Patient Scheduling And Coordination

    Data Management And Tracking Of Patient Outcomes

    6.12. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Compliance Tracking

    Quality Assurance And Control

    6.13. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Real-Time Tracking Of Shipments

    Chain Of Custody Documentation

    7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

    7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

    8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Cell And Gene Therapy Supply Chain/Logistics Market

    9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview

    9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Cell And Gene Therapy Supply Chain/Logistics Market

    10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

    11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview

    11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

    12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

    13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

    14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview

    14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

    15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

    15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Cell And Gene Therapy Supply Chain/Logistics Market

    16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

    17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Cell And Gene Therapy Supply Chain/Logistics Market

    18.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

    19.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

    20.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

    21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

    21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

    22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Cell And Gene Therapy Supply Chain/Logistics Market

    23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview

    23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Cell And Gene Therapy Supply Chain/Logistics Market

    24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview

    24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

    25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview

    25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Cell And Gene Therapy Supply Chain/Logistics Market

    26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview

    26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

    27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

    28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview

    28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

    29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview

    29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

    30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape

    30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles

    30.2.1. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. United Parcel Service Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Avantor Sciences Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

    31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

    31.1. Arvato Group

    31.2. Catalent Inc.

    31.3. Charles River Laboratories International

    31.4. Parexel International Corporation

    31.5. Cytiva

    31.6. Almac Group

    31.7. World Courier

    31.8. Sharp Packaging Services

    31.9. PCI Pharma Services

    31.10. Cryoport Inc.

    31.11. Brooks Life Sciences

    31.12. BioLife Solutions Inc.

    31.13. Biocair Inc.

    31.14. QuickSTAT

    31.15. Clarkston Consulting Inc.

    32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

    34. Recent Developments In The Cell And Gene Therapy Supply Chain/Logistics Market

    35. Cell And Gene Therapy Supply Chain/Logistics Market High Potential Countries, Segments and Strategies

    35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: AmerisourceBergen Corporation Financial Performance
  • Table 85: United Parcel Service Financial Performance
  • Table 86: Thermo Fisher Scientific Inc. Financial Performance
  • Table 87: Avantor Sciences Financial Performance
  • Table 88: Lonza Group AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: AmerisourceBergen Corporation Financial Performance
  • Figure 85: United Parcel Service Financial Performance
  • Figure 86: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 87: Avantor Sciences Financial Performance
  • Figure 88: Lonza Group AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Cell & Gene Therapy Manufacturing Services Global Market Report 2025 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Gene Editing Global Market Report 2025 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Culture Consumables And Equipment Global Market Report 2025 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Based Assays Global Market Report 2025 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Expansion Global Market Report 2025 – By Cell Type (Mammalian, Microbial, Other Cell Types), By Product (Consumables, Reagents, Media, Serum, Disposables, Instruments ), By Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications), By End-user (Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Supply Chain Management Global Market Report 2025 – By Component (Software Application, Hardware Type), By Delivery Mode (On-Premise, Cloud Based), By End-User (Healthcare Providers, Healthcare Manufacturers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Cell And Gene Therapy Supply Chain/Logistics market?

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain. For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here

How will the Cell And Gene Therapy Supply Chain/Logistics market drivers and restraints affect the market dynamics? What forces will shape the Cell And Gene Therapy Supply Chain/Logistics industry going forward?

The Cell And Gene Therapy Supply Chain/Logistics market major growth driver - The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics. For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here

What is the forecast market size or the forecast market value of the Cell And Gene Therapy Supply Chain/Logistics market?

The Cell And Gene Therapy Supply Chain/Logistics market size has grown strongly in recent years. The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification. For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here

How is the Cell And Gene Therapy Supply Chain/Logistics market segmented?

The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here

Which region has the largest share of the Cell And Gene Therapy Supply Chain/Logistics market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here.

Who are the major players in the Cell And Gene Therapy Supply Chain/Logistics market?

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd. . For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here.

What are the key trends in the Cell And Gene Therapy Supply Chain/Logistics market?

Major trends in the Cell And Gene Therapy Supply Chain/Logistics market include Advancements In Technology Propel Cell And Gene Therapy Logistics. For further insights on the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here.

What are the major opportunities in the Cell And Gene Therapy Supply Chain/Logistics market? What are the strategies for the Cell And Gene Therapy Supply Chain/Logistics market?

For detailed insights on the major opportunities and strategies in the Cell And Gene Therapy Supply Chain/Logistics market, request a sample here.

How does the Cell And Gene Therapy Supply Chain/Logistics market relate to the overall economy and other similar markets?

For detailed insights on Cell And Gene Therapy Supply Chain/Logistics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Cell And Gene Therapy Supply Chain/Logistics industry?

For detailed insights on the mergers and acquisitions in the Cell And Gene Therapy Supply Chain/Logistics industry, request a sample here.

What are the key dynamics influencing the Cell And Gene Therapy Supply Chain/Logistics market growth? SWOT analysis of the Cell And Gene Therapy Supply Chain/Logistics market.

For detailed insights on the key dynamics influencing the Cell And Gene Therapy Supply Chain/Logistics market growth and SWOT analysis of the Cell And Gene Therapy Supply Chain/Logistics industry, request a sample here.